| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $40.1M | 0.06% | 1.52M | +26% | Q2 2026 |
| Oaktree Capital · Howard Marks | $10.3M | 0.14% | 10.21M | −36% | Q2 2026 |
| Bridgewater Associates · Ray Dalio | $1.1M | 0.00% | 41.65K | −46% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NVST trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Reis MischaOfficer | Sale at price 27.50 per share. | 8K | $220.00K |
| Aug 17, 2026 | Keel Paul AChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 179.7K | — |
| May 18, 2026 | Pierce James AndrewDirector | Stock Award(Grant) at price 0.00 per share. | 9.3K | — |
| May 18, 2026 | Gallahue Kieran T.Director | Stock Award(Grant) at price 0.00 per share. | 9.3K | — |
| May 18, 2026 | Raskas Daniel ADirector | Stock Award(Grant) at price 0.00 per share. | 9.3K | — |
| May 18, 2026 | Tsingos Christine ADirector | Stock Award(Grant) at price 0.00 per share. | 9.3K | — |
| May 18, 2026 | Jain VivekDirector | Stock Award(Grant) at price 0.00 per share. | 9.3K | — |
| May 18, 2026 | Carruthers WendyDirector | Stock Award(Grant) at price 0.00 per share. | 9.3K | — |
| May 18, 2026 | Huennekens R ScottDirector | Stock Award(Grant) at price 0.00 per share. | 12.6K | — |
| Feb 24, 2026 | Kaabi Faez COfficer | Stock Award(Grant) at price 0.00 per share. | 13.5K | — |
| Feb 24, 2026 | Befidi Robert Jr.Officer | Stock Award(Grant) at price 0.00 per share. | 7.6K | — |
| Feb 24, 2026 | Acurio VeronicaOfficer | Stock Award(Grant) at price 0.00 per share. | 7.6K | — |
| Feb 24, 2026 | Nilsson StefanOfficer | Stock Award(Grant) at price 0.00 per share. | 7.6K | — |
| Feb 24, 2026 | Hammes Eric D.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 16.1K | — |
| Feb 24, 2026 | Keel Paul AChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 48.7K | — |
| Feb 24, 2026 | Nance Mark EGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 12.7K | — |
| Feb 24, 2026 | Reis MischaOfficer | Stock Award(Grant) at price 0.00 per share. | 5.9K | — |
| Feb 9, 2026 | Reis MischaOfficer | Sale at price 30.00 per share. | 9.7K | $290.25K |
| Feb 9, 2026 | Reis MischaOfficer | Conversion of Exercise of derivative security at price 15.97 - 19.04 per share. | 9.7K | $166.92K |
| Aug 24, 2025 | Reis MischaOfficer | Sale at price 21.60 per share. | 15K | $324.00K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.1 | 24.5 | -13.1 | 2.2 | -9.2 | 11.9 | 3.6 | -0.6 | -13.5 | -3.2 | +4.7% | ||
| 2025 | 6.4 | -2.6 | -13.6 | -6.8 | 13.6 | 7.0 | -3.3 | 12.1 | -3.8 | -0.1 | 2.7 | 3.9 | +12.5% |
| 2024 | -2.3 | -12.1 | 3.5 | -8.0 | -1.6 | -14.1 | 2.6 | 7.0 | 8.2 | 6.1 | 6.3 | -13.5 | −19.8% |
| 2023 | 15.8 | -0.8 | 5.7 | -5.8 | -17.1 | 6.1 | 1.7 | -6.9 | -12.9 | -16.5 | -2.5 | 6.0 | −28.5% |
| 2022 | -4.0 | 11.0 | 1.5 | -18.7 | 8.6 | -10.5 | 5.5 | -8.8 | -11.5 | 0.6 | 3.4 | -1.3 | −25.3% |
| 2021 | 5.4 | 8.4 | 5.9 | 6.1 | 0.8 | -1.0 | -0.3 | -0.7 | -2.3 | -6.5 | -0.8 | 16.1 | +33.6% |
| 2020 | -0.2 | -14.2 | -41.1 | 30.3 | 8.6 | -0.2 | 3.7 | 9.7 | 2.9 | 7.1 | 12.5 | 13.5 | +13.8% |
| 2019 | 5.2 | -4.1 | 5.4 | +6.3% |
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Buy / hold / sell counts